Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis

NCT04535999 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT04535999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04535999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis
Lead sponsor
University of Pennsylvania
Phase
Phase 4
Overall status
Completed
Start date
February 7, 2022
Completion date
May 30, 2025
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis